← back to search

Rongjun Cui

Harbin Medical University · CN
Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research focused on Cancer research and Prostate cancer, with related work in DU145, Competing endogenous RNA, Vimentin. Notable publications include 'OCT4B modulates OCT4A expression as ceRNA in tumor cells', 'Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway', and 'Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma'.
h-index
citations
429
works
14
NIH funding
primary concept
email

Recent publications

A cross-sectional study exploring relationships between triglyceride glucose index, atherogenic index of plasma, and chronic pain: NHANES 1999–2004
Lipids in Health and Disease 2025cited by 6position: lastdoi
LncRNA <i>AC245100.4</i> Binds HSP90 to Promote the Proliferation of Prostate Cancer
Epigenomics 2020cited by 24position: firstdoi
Downregulation of miR-146b-5p via iodine involvement repressed papillary thyroid carcinoma cell proliferation
Journal of Molecular Endocrinology 2020cited by 14position: middledoi
miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma
Cancer Medicine 2019cited by 40position: firstdoi
&lt;p&gt;LINC00491 as a new molecular marker can promote the proliferation, migration and invasion of colon adenocarcinoma cells&lt;/p&gt;
OncoTargets and Therapy 2019cited by 32position: lastdoi
Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma
Cellular Physiology and Biochemistry 2018cited by 53position: middledoi
Prostate cancer cell proliferation is suppressed by microRNA‑3160‑5p via targeting of F‑box and WD repeat domain containing 8
Oncology Letters 2018cited by 12position: middledoi
Role of RbBP5 and H3K4me3 in the vicinity of Snail transcription start site during epithelial-mesenchymal transition in prostate cancer cell
Oncotarget 2016cited by 19position: middledoi
OCT4B modulates OCT4A expression as ceRNA in tumor cells
Oncology Reports 2015cited by 55position: middledoi
CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells
Oncology Reports 2015cited by 44position: middledoi
Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition
Molecular Medicine Reports 2015cited by 31position: middledoi
Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway
Molecular Medicine Reports 2014cited by 54position: middledoi
MicroRNA-124 regulates TGF-α-induced epithelial-mesenchymal transition in human prostate cancer cells
International Journal of Oncology 2014cited by 33position: middledoi
DNA methylation inhibitor, decitabine, promotes MGC803 gastric cancer cell migration and invasion via the upregulation of NEDD4-1
Molecular Medicine Reports 2012cited by 12position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaoguang Yu · Harbin Medical University11 papers (2012–2020)Jiebing Tang · Harbin Medical University8 papers (2012–2020)Dong Li · Harbin Medical University6 papers (2014–2018)Ping Lin · Harbin Medical University6 papers (2012–2020)Xiulan Zheng · Harbin Medical University6 papers (2014–2019)Yujia Pan · Sun Yat-sen University Cancer Center6 papers (2014–2020)Chi Liu · Guangzhou University of Chinese Medicine4 papers (2018–2020)Hui Sun · Harbin Medical University4 papers (2012–2018)Jialin Fan · Harbin Medical University4 papers (2016–2020)Jingyi Bu · Harbin Medical University3 papers (2012–2015)Ping Lin · Harbin Medical University3 papers (2014–2018)Chunyan Xu · Harbin Medical University3 papers (2012–2015)Yandan Du · Harbin Medical University3 papers (2012–2015)Zhengkai Yang · Harbin Medical University3 papers (2012–2018)Hui Xie · University of Iowa2 papers (2018–2020)Hui Sun · Harbin Medical University2 papers (2015–2015)Tianhu Zheng · Harbin Medical University2 papers (2018–2020)Xiulan Zheng · Harbin Medical University2 papers (2015–2018)Wenjing Sun · Nanjing University of Chinese Medicine2 papers (2016–2018)Lijuan Zhu · South China Agricultural University2 papers (2015–2018)